Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0001209191-20-018220

Options or other derivatives

  • Director acquired 29,271 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BARBARI SHARON SURREY · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-03-09 Grant or award : show line 1 in the form Stock Options +29,271 $4.50 2029-05-16 29,271 29,271 D
Loading xslF345X03/doc4.xml…